Tech Company Financing Transactions
Antogen Funding Round
iGrow Venture Partners and private investors participated in a Seed venture round for Antogen. The financing round was announced on 6/9/2026.
Transaction Overview
Company Name
Announced On
6/9/2026
Transaction Type
Venture Equity
Amount
Unknown
Round
Seed
Investors
iGrow Venture Partners (Lead Investor)
Proceeds Purpose
The company intends to use the funds to support continued development of its proteomics platform, advanced machine learning models, and proprietary biological datasets, while expanding its scientific and operational capabilities.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
333 S State Ave
Indianapolis, IN 46201
USA
Indianapolis, IN 46201
USA
Phone
Website
Email Address
Not Recorded
Overview
Antogen enables antigen discovery and translational decision-making through high-quality Human Leukocyte Antigen (HLA) testing and immunopeptidomics. What we do: Target discovery and prioritization; Validation and risk reduction for clinical assets; Translational planning for HLA-restricted therapeutic programs; Clinical trial eligibility testing where HLA status determines enrollment.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Zachary Antovich
Browse more venture capital transactions:
Prev: 6/9/2026: Stepful venture capital transaction
Next: 6/9/2026: Harness Therapeutics venture capital transaction
Share this article
Where The Data Comes From
We do our best to document tech company VC transactions. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs